Baxalta (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Baxalta" in Spanish language version.

refsWebsite

Global rank Spanish rank

3genengnews.com

low place

low place

2^nd place

2^nd place

1fiercebiotech.com

low place

low place

6,282^nd place

low place

79^th place

179^th place

41^st place

85^th place

1asianscientist.com

low place

low place

1seekingalpha.com

5,344^th place

8,266^th place

asianscientist.com

«Takeda Completes Acquisition Of Shire». Asian Scientist Magazine | Science, technology and medical news updates from Asia (en inglés estadounidense). 21 de enero de 2019. Consultado el 23 de enero de 2019.

doi.org

dx.doi.org

Timmins, Peter (January 2015). «Industry Update». Therapeutic Delivery 6 (1): 9-15. doi:10.4155/tde.14.103.

fiercebiotech.com

«Baxalta: Baxter's newly named biopharma spinout has had its ups and downs». FierceBiotech.

genengnews.com

Staff (1 de abril de 2015). «Baxter Acquires SuppreMol and Its Immunoregulatory Therapy Pipeline». Gen. Eng. Biotechnol. News|Genetic Engineering & Biotechnology News (Paper) 35 (7): 10.
«Shire Offers $30B for Baxalta». GEN.
«Shire, Baxalta Tie the Knot in $32B Merger | GEN». Genengnews.com. 11 de enero de 2016. Consultado el 27 de enero de 2017.

law360.com

«Baxter Expands Cancer Therapies With $900M Oncaspar Buy». law360.com.

seekingalpha.com

Minkoff, SA Editor Yoel (8 de enero de 2019). «Takeda Pharmaceutical completes Shire acquisition». Seeking Alpha (en inglés). Consultado el 23 de enero de 2019.

usatoday.com

Kevin McCoy, USA TODAY (4 de agosto de 2015). «Pharma mania: Shire offers $30B for Baxalta». USA TODAY.

wsj.com

Tess Stynes (4 de agosto de 2015). «Shire Makes Unsolicited $30 Billion Bid for Baxalta». WSJ.